Latest / Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular risk and how ongoing phase 3 research may shape future management of patients with elevated lipoprotein(a).
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.
Learn more.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.